Latest CFRX reports update at 2023-11-14: 2023-Q32022-Q42022-Q3
ContraFect Corporation logo

ContraFect Corporation CFRX

$ 1.47 -5.16%

Country

usaUSA

IPO year

2014

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

CEO

Dr. Roger Pomerantz

Employees in the company

24

Shares

521 K

Market Cap[1]

$ 5.39 M

EBITDA (LTM)

$ -66.5 M

P/E (LTM)

-0.04

P/S (LTM)

-

EPS (LTM)

-37.85

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.